Prosfektif Metode Sampel Darah Kering dalam Bioanalisis
Keywords:
dried blood spot, bioanalysis, pharmacokinetic, therapeutic drug monitoringAbstract
Biosampling of dried blood spot method became lately very interested in bioanalysis, some of the advantages given in this method compared to conventional venous canulla (venipuncture); less invasive making it more pleasant for the patient or subject, requires small volume, requires simple transportation process and storage did not need special equipment, suod stabilizes analit and reduces risk of infection. The method of dried blood spot is done by invasive light on the finger or heel prick and then spike on filter paper and dried at room temperature or under nitrogen flow with controlled humidity and stored in bag with desiccant packages, than it analyzed using validation bioanalyzing method. Dried blood spot method can be applied on bioanalysis test for pharmacokinetic, toksikokinetic , epidemiologic and Teurapeutic drug monitoring.
Downloads
References
1. Borremans B. (2014) Ammonium improves elution of fixed dried blood spots without affecting immunofluorescence assay quality. Trop. Med. Int. Health. DOI: 10.1111/tmi.12259
2. Chambers A.G., Andrew J.P., Juncong Y., Alexander G.C., & Christoph H.B. (2013) Multiplexed Quantitation of Endogenous Proteins in Dried Blood Spots by Multiple Reaction Monitoring - Mass Spectrometry. The American Society for Biochemistry and Molecular Biology, 12 (3), pp. 781–791
3. Clark T.G & Julian J.H. (2011) Utilization of DBS within drug discovery: a simple 2D-LC–MS/MS system to minimize blood- and paper- based matrix effects from FTA elute™ DBS. Bioanalysis, 3(11), pp. 1253–1270
4. Clavel M.S., & Petra H. (2015) Analysis of metformin, sitagliptin and creatinine in human dried blood spots. Journal of Chromatography B, 997, pp. 218–228
5. Dainty T.C., Richmond E.S., Davies
I. & Blackwell M.P. (2012) Dried blood spot bioanalysis: an evaluation of techniques and opportunities toxicokinetic studies. Int J Toxicol. 31(1), pp 4-13
6. Déglon J., Aurélien T., Patrice M., & Christian S. (2012) Direct analysis of dried blood spots coupled with mass spectrometry: concepts and biomedical applications. Anal. Bioanal. Chem., 402, pp. 2485–2498
7. Demirev A.F. (2013) Dried blood spots: Analysis and applications. Anal.Chem. 85, 779
8. Dieter Z., Stephan H., Beatrice B., Stephan S., Christoph F., & Matthias
L. (2013) Internal standard application to dried blood spots by spraying: investigation of the internal standard distribution. Bioanalysis, 5(6), pp. 711–719
9. Edwards R.L., Andrew J.C., Mark B., Paul G., Josephine B., & Helen J.C. (2011) Hemoglobin Variant Analysis via Direct Surface Sampling of Dried Blood Spots Coupled with High - Resolution Mass Spectrometry. Anal. Chem., 83, pp. 2265–2270
10. EMA (2011) Guideline on bioanalytical method validation European Medicine Agency London:
pp. 4-10
11. Enaksha R.W., Basira G.A., Naijia H.H., John W.R., Jennifer L.H., Kenneth J.R., Everett J.P., & Ajai
K.C. (2011) Dried blood spot sampling: coupling bioanalytical feasibility, blood–plasma partitioning and transferability to in vivo preclinical studies. Bioanalysis, 3(14), pp. 1635–1646
12. EQA (2005) Blood Collection and Handling Dried Blood Spot (Modul 14). Available at: http://www.who.int/diagnostics_labor atory/documents/guidance/pm_modul e14.pdf [10 September 2015].
13. Evans C., Mark A., Peter B., Jeffrey D., Christopher A.J., Wenkui L., Steve L., Luca M., Timothy O., Philip T., Xiaomin W., Enaksha W., John W., Eric W., & Patricia Z. (2015) Implementing Dried Blood Spot Sampling for Clinical Pharmacokinetic Determinations: Considerations from the IQ Consortium Microsampling Working Group. The AAPS Journal, Vol. 17, No. 2, pp. 292-300
14. FDA (2001) Guidance for Industry Bioanalytical Method Validation.
Food and Drug Administration United States of America: Department of Health and Human Services.
15. FDA. 510(K) SUMMARY. Available
at: http://www.accessdata.fda.gov/cdrh_ docs/pdf12/k121864.pdf [8 oktober
2015]
16. Ingels A., Lambert W.E. & Stove
C.P. (2010) Determination of gamma- hydroxybutyric acid in dried blood spots using a simple GC–MS method with direct ‘on spot’ derivatization. Anal. Bioanal. Chem. 398(5), pp. 2173–2182
17. Jager N.G.L., Hilde R., Jan H.M.S., & Jos H.B. (2014) Determination of tamoxifen and endoxifen in dried blood spots using LC–MS/MS and the effect of coated DBS cards on recovery and matrix effects. Bioanalysis, 6(22), pp. 2999–3009
18. Jager N.G.L., Hilde R., Jan H.M.S., & Jos H.B. (2014) Procedures and practices for the validation of bioanalytical methods using dried blood spots: a review. Bioanalysis. 6(18), pp. 2481–2514
19. Kesel P.M.M., Nele S., Sara C., Willy E.L., & Christophe P.S. (2013) Hemato-critical issues in quantitative analysis of dried blood spots: challenges and solutions. Bioanalysis, 5(16), pp. 2023–2041
20. La Marca G, Giocaliere E. & Villanelli F. (2012) Development of an UPLC–MS/MS method for the determination of antibiotic ertapenem on dried blood spots. J. Pharm. Biomed. Anal. 61, pp. 108–113
21. Liang X., Yang L., Berezhkovskiy L, Liederer B., Nguyen T, Jia Y., Schweiger W.,Dean B. & Deng Y. (2011) Evaluation of dried blood spot sampling following cassette dosing in drug discovery. Bioanalysis, 3, 2291.
22. Liu G., Heidi M.S., & Qin C.J. (2011)
Internal standard tracked dilution to overcome challenges in dried blood
spots and robotic sample preparation for liquid chromatography/tandem mass spectrometry assays. Rapid Commun. Mass Spectrom, 25, pp. 1250–1256
23. Liu G., Ji Q.C., Jemal M., Tymiak
A.A. & Arnold M.E. (2011)
Approach to evaluating dried blood spot sample stability during drying process and discovery of a treated card to maintain analyte stability by rapid on-card pH modification. Anal. Chem. 83, 9033.
24. Maria C.H., Emile H.M., and Jan A.O., 2015. Hematocrit-independent recovery of immunosuppressants from DBS using heated flow-through desorption. Bioanalysis, 7(16), pp. 2019–2029
25. Martin N.J. & Helen J.C. (2014) Challenges and opportunities in mass spectrometric analysis of proteins from dried bloodspots. Expert Rev. Proteomics, 11(6), pp. 685–695
26. Neil Spooner (2013). A dried blood spot update: still an important bioanalytical technique. Bioanalysis, 5(8), pp. 879–883
27. Nikolay Y., osée M., Sylvain L., Jean N.M., Annik B., Milton F., Marianne R., Pascal G., Marc L., Robert B.M. & Fabio G. (2010) Determination of naproxen using DBS: evaluation & pharmacokinetic comparison of human plasma versus human blood DBS. Bioanalysis, 2(8), pp. 1501–
1513
28. Odoardi S., Luca A. & Sabina S.R. (2014). Simplifying sample pretreatment: Application of dried blood spot (DBS) method to blood samples, including postmortem, for UHPLC–MS/MS analysis of drugs of abuse. Forensic Science International, 243, pp. 61–67
29. Oliveira R.V., Jack H. & Enaksha W. (2014) Fully-Automated Approach for Online Dried Blood Spot Extractionand Bioanalysis by Two- Dimensional-Liquid
ChromatographyCoupled with High- Resolution Quadrupole Time-of- Flight Mass Spectrometry. Anal. Chem. 86, pp. 1246−1253
30. O’Mara M., Hudson B.C., Olson K., Yueh Y., Dunn J. & Spooner N. (2011) The effect of hematocrit and punch location on assay bias during quantitative bioanalysis of dried blood spot samples. Bioanalysis, 3(20), pp. 2335–2347
31. Philip D. & Neil S. (2010) The effect of hematocrit on assay bias when using DBS samples for the quantitative bioanalysis of drugs. Bioanalysis, 2(8), pp. 1385–1395
32. Rizwana Q., Raka J. & Atul A. (2013) The use of dried blood spot samples in screening drugs of abuse. Pharmacology & Pharmacy. 4, pp. 152-159
33. Rowland M. & Gary T.E. (2010) Use of Dried Blood Spots in Drug Development: Pharmacokinetic Considerations. The AAPS Journal, Vol. 12, No. 3, pp. 290-293
34. Sharma A., Swati J., Mahendra S. & Jawahar L. (2014) Dried blood spots: Concepts, present status, and future perspectives in bioanalysis. Drug Test. Analysis. DOI 10.1002/dta.1646
35. Soto M., Roger P., Valerie A., Mylowagner, Ronya P., Manuel P., James M., Christopher A.J., Kevin
L.S. & Marc W.R. (2014) Evaluation of matrix microsampling methods for therapeutic drug candidate quantification in discovery-stage rodent pharmacokinetic studies. Bioanalysis, 6(16), pp. 2135–2146
36. Tanna S., Dennis B. & Graham L. (2015) LC-HRMS Analysis of Dried Blood Spot Samples for Assessing Adherence to Cardiovascular Medications. J. Bioanal. Biomed. Volume 7(1), pp. 001-068
37. Timmerman P., White S., Globig S., Ludtke S., Brunet L. & Smeraglia J. (2011) EBF recommendation on the validation of bioanalytical methods for dried blood spots. Bioanalysis.;3:1567–75.
38. Vu D.H., Koster R.A., Bolhuis M.S., Greijdanus B., Altena R.V., Nguyen D.H, Brouwers J.R.B.J., Uges D.R.A. & CAlffenaar J.W. (2014) Simultaneous determination of rifampicin, clarithromycin and their metabolites in dried blood spots using LC–MS/MS.Talanta, 121, pp. 9–17
39. Wenkui Li and Francis L.S.T., 2010. Dried blood spot sampling in combination with LC-MS/MS for quantitative analysis of small molecules. Biomed. Chromatogr., 24,
pp. 49–65
40. Wenkui Li., John D., Paul M., Jimmy
F. & Francis L.S.T. (2015) LC–
MS/MS bioanalysis of loratadine (Claritin in dried blood spot (DBS) samples collected by subjects in a clinical research study. Journal of Chromatography B, 983–984, pp. 117–124
41. Wilhelm A.J., Jeroen C.G., Burger D. & Eleonora L.S. (2014) Therapeutic Drug Monitoring by Dried Blood Spot: Progress to Date and Future Directions. Clin. Pharmacokinet, 53,
pp. 961–973
42. Zanet D.L., Saberi L., Oliveira L., Sattha B., Gadawski I. & Cote. H.C. (2013) Blood and dried blood spot telomere length measurement by qPCR: Assay considerations. PLoS One, 8, e57787.
43. Zhang Z., Wei X., Nicholas E.M., Graham R.C. & Zheng O. (2012) Silica Coated Paper Substrate for Paper-Spray Analysis of Therapeutic Drugs in Dried Blood Spots. Anal. Chem. 84, pp. 931−938
